Showing results (31-40 of 442) with videos related to

Sort By:
Pageof 45
Journal of Crohn'S & Colitis|April 3, 2012
Implementing changes in clinical practice to improve the management of Crohn's diseaseRemo Panaccione, Toshifumi Hibi, Laurent Peyrin-Biroulet, et al.
Journal of Inflammation Research|February 16, 2018
Clinical utility of ustekinumab in Crohn's diseasePaulo Gustavo Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Canadian Journal of Gastroenterology & Hepatology|May 13, 2015
Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic reviewTravis Murdoch, Sarah O'Donnell, Mark S Silverberg, et al.
Expert Review of Gastroenterology & Hepatology|July 13, 2018
Fistula-associated anal carcinoma in Crohn's diseaseTakayuki Yamamoto, Paulo Gustavo Kotze, Antonino Spinelli, et al.
Canadian Journal of Gastroenterology & Hepatology|August 8, 2014
Management of the pregnant inflammatory bowel disease patient on anti-tumour necrosis factor: state of the art and future directionsYvette Leung, Remo Panaccione, Subrata Ghosh, et al.
Canadian Journal of Gastroenterology & Hepatology|July 1, 2015
Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel diseaseBrian Bressler, Remo Panaccione, Richard N Fedorak, et al.
The American Journal of Gastroenterology|September 28, 2004
Isolated visceral small artery fibromuscular hyperplasia-induced ischemic colitis mimicking inflammatory bowel diseaseSen Ian Gan, Stefan Urbanski, Sylvain P Coderre, et al.
Intestinal Research|May 20, 2017
Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfallsPaulo Gustavo Kotze, Subrata Ghosh, Willem A Bemelman, et al.
Inflammatory Intestinal Diseases|February 28, 2022
Early Laparoscopic Ileal Resection for Localized Ileocecal Crohn's Disease: Hard Sell or a Revolutionary New Norm?Beatriz Yuki Maruyama, Christopher Ma, Remo Panaccione, et al.
Inflammatory Bowel Diseases|September 18, 2010
Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel diseaseCarla S Coffin, Hughie F Fraser, Remo Panaccione, et al.
Pageof 45